Isotechnika Receives European Patent for Lead Immunosuppressive Drug, ISA247
3rd Oct 2006, 18:48 GMT
Isotechnika Inc. [Pressemappe] Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has been issued European Patent No. EP0991660 for its lead immunosuppressive drug, ISA247. The patent entitled "DEUTERATED AND UNDEUTERATED CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS" is the ninth patent to be issued internationally in this patent family. Patents relating to these claims have issued in the following countries; ... Lesen Sie hier weiter...
Isotechnika Receives European Patent for Lead Immunosuppressive Drug, ISA247 related news:
- Isotechnika Receives No Objection Letter From Health Canada for Second Phase III Psoriasis Clinical Trial — Presseportal.de Wirtschaft
- Celgene Rising on Positive Data from Pipeline Product and CV Therapeutics Receives Notices of Allowance from U.S. Patent and Trademark Office and European Patent Office for Drug-Eluting Stent Technology — Financial News USA (OTC: FNWU)
- New European Apple patent for networked media station — PVR Wire
- NBA receives pitch for all-European division (AFP) — Yahoo! News: Sports News
- If You License A Patent, Does That Mean You Think It's Valid? — Techdirt
- Patent protection 'key to Europe's knowledge economy' — EurekAlert! - Policy and Ethics
- Isotechnika to update investment community at BIOContact — Pharmaceuticals News from StratCenter.com
- VeraLight Receives USPTO Notice of Allowance Covering Dermal Fluorescence Technology to Detect Diabetes — RedOrbit News - Health
- Court Case on Patent Overlap — Technocrat
- Curis Issued US Patent Covering Hedgehog Pathway Agonists — Pharmaceuticals News from StratCenter.com
Latest news from Presseportal.de Wirtschaft:
- Verizon Business und MPS Broadband erweitern Beziehung
- ARTWORXX mit neuen Kunden für Ungarn und Polen
- Commerzbank-Börsenbericht vom 13.11. bis 17.11.2006
- Nachrichten aus Berlin (1639) - 5. Jahreskongress Deutscher Wirtschaftsförderer in Berlin
- Louisiana Superdome Sports Nortel Secure Converged Network for Anywhere, Anytime Game Action
- New Study Indicates Boosted Invirase 500 Patients Achieve Similar Levels of Viral Suppression to Boosted Lopinavir but with a Better Lipid Profile
- Micrel führt neuen stromsparenden LDO ein, der die Batteriehaltbarkeit für tragbare Verbraucheranwendungen verlängert
- Konrad-Adenauer-Stiftung verleiht Preis Soziale Marktwirtschaft / Festakt am 16. November in der Frankfurter Paulskirche mit Annette Schavan, Bernhard Vogel und Günter Baumann
- Neue Forschungsergebnisse [1] erfordern Neueinstufung von ZOLADEX als kuratives Heilmittel
- Der PENNYSTOCK REPORT empfiehlt: Immune Response Corp. - Der Entwicklungskurs zeigt steil nach oben!